Industry Research Reports

Home > Reports > New Technology > Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: New Technology

Published Date: 2026-08-02

Pages: 110 Pages

Report ld: 6985170

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

biaoTi Key Findings

In 2025, global production of Kidney-Organ Chip was approximately 22,599 units.

Commercial models concentrate on proximal tubule and nephrotoxicity applications

Human cells and controlled perfusion improve renal physiological relevance

Drug developers and research institutions remain the primary customer groups

Assay-ready systems reduce operational barriers for pharmaceutical laboratories

Standardization and regulatory validation determine long-term market scalability

Kidney-Organ Chip Market Size(US$)

CAGR 2026-2032

10.5%

Market Size,2032

USD 73.18

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 40.18 million

Market Forecast in 2032(Value)

US$ 73.18 million

CAGR

10.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Kidney-Organ Chip was estimated to be worth US$ 35.29 million in 2025 and is projected to reach US$ 73.18 million, growing at a CAGR of 10.5% from 2026 to 2032.

A Kidney-Organ Chip, more commonly described as a Kidney Organ-on-a-Chip, is a microengineered in vitro platform designed to reproduce selected structural, mechanical, and physiological characteristics of the human kidney. The system combines human renal cells with microfluidic channels, porous membranes, extracellular matrices, controlled perfusion, and biochemical stimulation to simulate kidney functions under dynamic conditions. Depending on the model design, it may replicate the glomerular filtration barrier, proximal-tubule secretion and reabsorption, distal-tubule transport, collecting-duct function, renal vasculature, or interactions among several nephron segments. Kidney-Organ Chips are primarily used in nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic research, and development of personalized therapies. The market scope includes blank microfluidic chips, cell-loaded assay-ready models, kidney organoid-on-chip products, perfusion instruments, pumps, sensors, culture media, cells, software, analytical services, customized model development, training, and maintenance. These products are laboratory research and drug-development tools rather than implantable chips, dialysis systems, or therapeutic artificial kidneys.

biaoTi Market Trends

Kidney-Organ Chip technology is progressing from basic single-channel cell-culture devices toward multicellular, vascularized, organoid-based, and interconnected renal models. Developers increasingly use human primary cells, immortalized renal cell lines, induced pluripotent stem-cell-derived cells, and adult stem-cell-derived organoids to improve physiological relevance. Dynamic perfusion and controlled shear stress support cell polarity, transporter expression, and long-term renal function. Another major trend is the development of standardized, microplate-compatible products that support automated liquid handling, high-content imaging, and medium- to high-throughput compound testing. Cell-loaded assay-ready models are becoming more important because they reduce model-establishment time and operator-dependent variability. Integrated sensors, real-time imaging, artificial-intelligence-assisted analysis, and transcriptomic or proteomic measurements are expanding functional readouts. Multi-organ configurations linking the kidney with the liver, intestine, heart, muscle, or immune system are also gaining attention for evaluating drug metabolism, systemic exposure, renal clearance, and inter-organ toxicity. These developments are gradually moving Kidney-Organ Chips from academic prototypes toward practical preclinical tools.

Market Segmentation

By Company

Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Draper Laboratory
Nortis
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Glomerular Chip
Renal Tubule Chip
Colliding Duct Chip

Segment by Application

Hospitals
Research Institutions
Universities
Others

Segment by Category

Membrane-Based Dual-Channel Type
3D Matrix-Embedded Tubular Type

Segment by Division

Primary Human Cell-Based Type
Immortalized Cell Line-Based Type
Stem Cell & Organoid-Based Type

biaoTi Market Dynamics

Drivers

The primary market driver is the need to detect drug-induced kidney injury earlier and more accurately during pharmaceutical development. Renal toxicity can result in program termination, clinical failure, restricted dosing, additional monitoring requirements, or post-market safety concerns. Conventional models may not reproduce the polarity, transporter activity, fluid flow, and epithelial-vascular interactions of the human kidney. Kidney-Organ Chips provide controlled environments for measuring drug exposure, secretion, reabsorption, permeability, biomarker release, and tissue injury over time. Growing research activity in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited renal disorders is also expanding demand for human disease models. Additional growth factors include advances in microfluidics, stem-cell differentiation, organoid culture, three-dimensional tissue engineering, and automated imaging. Policies promoting alternatives to animal testing and pharmaceutical investment in human-relevant models further support adoption. Together, these drivers are extending Kidney-Organ Chip use from academic research to mechanistic toxicology, compound screening, translational studies, and preclinical decision support.

Restraints

Commercial expansion is restrained by the biological complexity of the kidney and the lack of universally accepted validation standards. The kidney contains multiple nephron segments, specialized epithelial cells, endothelial cells, stromal cells, immune components, and complex vascular structures responsible for filtration, secretion, reabsorption, concentration, and endocrine regulation. Most commercial models reproduce only selected functions rather than the complete organ. Human primary renal cells may exhibit donor variability and limited expansion, while immortalized or stem-cell-derived cells may not fully achieve adult tissue maturity. Microfluidic systems may experience bubbles, evaporation, contamination, inconsistent flow, material absorption, and operational complexity. Customers can also require specialized pumps, imaging equipment, analytical methods, and trained personnel. Differences in chip geometry, cell type, extracellular matrix, medium, flow rate, exposure protocol, and endpoint selection reduce comparability between platforms. Until reference compounds, performance criteria, interlaboratory studies, and regulatory pathways become more established, Kidney-Organ Chips will mainly complement rather than completely replace existing preclinical methods.

Opportunities

The strongest commercial opportunities lie in standardized and assay-ready Kidney-Organ Chip models that provide reproducible results with limited user preparation. Pharmaceutical companies require scalable platforms for nephrotoxicity screening, renal transporter analysis, biomarker assessment, compound prioritization, and mechanism-of-injury studies. Disease-specific models constructed from patient-derived cells or induced pluripotent stem cells offer opportunities in rare kidney diseases, inherited disorders, precision medicine, and individualized therapeutic development. Multi-organ systems connecting the kidney with the liver, intestine, muscle, heart, or immune system can support pharmacokinetic, metabolism, systemic toxicity, and organ-interaction studies. Suppliers can also expand through customized model development, contract testing, data analysis, regulatory consulting, software, training, and cell-and-reagent packages. Compatibility with automated laboratory workflows and standard microplate formats could accelerate adoption by large pharmaceutical organizations. China, Japan, and South Korea offer additional opportunities through expanding biopharmaceutical research, microfluidic manufacturing capabilities, organoid programs, and policies supporting alternatives to animal testing. Partnerships with contract research organizations and cell suppliers can further strengthen market access.

Challenges

The principal challenge is generating biologically meaningful and repeatable data suitable for pharmaceutical and regulatory decisions. Renal cells must maintain appropriate polarity, transporter expression, barrier integrity, metabolic activity, and responses to physiological flow throughout the required culture period. Variations in cell source, extracellular matrix, medium composition, chip material, flow conditions, and dosing procedures can materially affect results. Developers must also establish clinically relevant endpoints, including transport activity, permeability, morphology, gene expression, tissue-injury biomarkers, and recovery responses. Scaling from laboratory prototypes to standardized commercial products requires consistent microfabrication, membrane quality, surface treatment, sterilization, cell loading, packaging, storage, and shipment. Another challenge is balancing physiological complexity with throughput and operational simplicity. Highly complex vascularized or multi-organ models may offer stronger biological relevance but can be more difficult and expensive to operate. Wider adoption will require reference-compound testing, transparent performance benchmarks, standardized data formats, interlaboratory validation, and clearer regulatory acceptance of Kidney-Organ Chip evidence.

biaoTi Industry Chain Analysis

The upstream industry includes microfluidic polymers, glass substrates, porous membranes, extracellular matrices, surface coatings, renal cells, stem cells, organoids, culture media, growth factors, pumps, valves, tubing, sensors, imaging systems, and laboratory automation equipment. The quality of these inputs directly influences cell viability, flow stability, optical performance, compound absorption, and experimental reproducibility. Midstream companies design and manufacture microfluidic chips, integrate perfusion equipment, construct renal tissue models, optimize culture protocols, develop analytical software, validate biological functions, and provide assay-ready products or customized testing services. Their competitiveness depends on combining microengineering, cell biology, tissue engineering, pharmacology, and data analysis. Downstream customers include pharmaceutical and biotechnology companies, contract research organizations, universities, hospitals, government laboratories, chemical companies, cosmetics companies, and regulatory research institutions. Products reach customers through direct technical sales, specialized scientific distributors, collaborative development agreements, and contract-service models. Installation, training, model development, data interpretation, software support, and consumable supply constitute an important service layer.

biaoTi Segment Insights

By simulated renal structure, Kidney-Organ Chips can be divided into glomerulus-on-chip, proximal-tubule-on-chip, distal-tubule or collecting-duct models, and integrated nephron or multi-organ systems. Proximal-tubule models represent the most commercially developed segment because they support nephrotoxicity, secretion, reabsorption, and transporter studies. By technical architecture, the market includes membrane-based dual-channel devices, three-dimensional matrix-embedded tubular models, organoid-on-chip platforms, vascularized renal models, and bioprinted chips. By product form, products can be classified into blank chips and consumables, cell-loaded assay-ready models, perfusion instruments and complete systems, and customized testing services. By cell source, models use primary human renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, or adult stem-cell-derived organoids. Major applications include drug-induced nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic and ADME analysis, and personalized medicine. Selection depends on biological complexity, throughput, repeatability, operating difficulty, and required analytical endpoints.

biaoTi Downstream Market Opportunities

Drug-induced nephrotoxicity testing represents the leading downstream opportunity because pharmaceutical developers need to identify compounds that damage glomerular, tubular, vascular, or interstitial tissues before clinical trials. Kidney-Organ Chips can support dose-response analysis, compound ranking, transporter studies, biomarker evaluation, and investigation of injury mechanisms. Renal disease modeling offers opportunities in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited disorders. Drug-transport and clearance models can improve understanding of secretion, reabsorption, metabolite handling, and drug-drug interactions. Multi-organ systems enable analysis of metabolites generated by the liver, substances absorbed through the intestine, and systemic toxicity involving the kidney and other tissues. Patient-derived cells and kidney organoids create longer-term opportunities in precision medicine and individualized therapy selection. Pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions are the primary customers, while chemical, cosmetics, food, and environmental-safety organizations represent additional demand for renal toxicity assessment.

biaoTi Regional Insights

North America is an important center for Kidney-Organ Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe has also established a strong position in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney models, multi-organ systems, perfusion equipment, or enabling technologies. The region benefits from established pharmaceutical research, microfluidics expertise, and policies supporting non-animal testing. Asia-Pacific is developing rapidly as China, Japan, and South Korea increase investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic laboratory equipment. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic fabrication and three-dimensional organ-chip development. Regional expansion will depend on pharmaceutical partnerships, local cell resources, technical-service networks, regulatory validation, and the availability of trained users.

Fastest-Growing Region: Asia Pacific

XX.X
%
CAGR*
XXXX
US$ Million
XXXX
REGIONAL SHARE

By Type,2021-2032(US$ Million)

Glomerular Chip

Renal Tubule Chip

Colliding Duct Chip

By Application，2021-2032(US$ Million）

Hospitals

Research Institutions

Universities

Others

biaoTi Competitive Landscape Analysis

The competitive landscape includes dedicated Kidney-Organ Chip suppliers, broader organ-on-a-chip platform companies, perfusion-system manufacturers, microfluidic-device producers, and contract model-development providers. Emulate offers a validated Kidney-Chip model, while MIMETAS provides perfused kidney models and kidney organoid tubules through its OrganoPlate platform. Nortis is recognized for proximal-tubule chips, and TissUse develops kidney-containing multi-organ systems. CN Bio and Hesperos provide platforms capable of incorporating kidney tissues into single- or multi-organ studies. Creative Biolabs offers customized Kidney-Organ Chip development, while Kirkstall, BEOnChip, InSphero, Fluigent, and Microfluidics Innovation Center provide adaptable organ-chip, perfusion, or renal-model solutions. Asian participants include Beijing Daxiang Biotech, Nanosystems Japan, and EDmicBio. Competitive differentiation centers on renal physiological relevance, validated function, reproducibility, throughput, ease of use, cell quality, automation, data analysis, application support, and regulatory credibility rather than on microfluidic-chip production capacity alone.

biaoTi Report Scope

This report provides a comprehensive view of the global market for Kidney-Organ Chip, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Kidney-Organ Chip market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Kidney-Organ Chip.

biaoTi Chapter Outline

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Kidney-Organ Chip companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Kidney-Organ Chip revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Kidney-Organ Chip revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Kidney-Organ Chip Product Introduction

1.2 Global Kidney-Organ Chip Market Size Forecast (2021–2032)

1.3 Kidney-Organ Chip Market Trends & Drivers

1.3.1 Kidney-Organ Chip Industry Trends

1.3.2 Kidney-Organ Chip Market Drivers & Opportunities

1.3.3 Kidney-Organ Chip Market Challenges

1.3.4 Kidney-Organ Chip Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Kidney-Organ Chip Players Revenue Ranking (2025)

2.2 Global Kidney-Organ Chip Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Kidney-Organ Chip Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Kidney-Organ Chip

2.6 Kidney-Organ Chip Market Competitive Analysis

2.6.1 Kidney-Organ Chip Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Kidney-Organ Chip Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Kidney-Organ Chip revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Kidney-Organ Chip Market Classification

3.1 Introduction by Type

3.1.1 Glomerular Chip

3.1.2 Renal Tubule Chip

3.1.3 Colliding Duct Chip

3.1.4 Global Kidney-Organ Chip Sales Value by Type

3.1.4.1 Global Kidney-Organ Chip Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Kidney-Organ Chip Sales Value, by Type (2021–2032)

3.1.4.3 Global Kidney-Organ Chip Sales Value, by Type (%), 2021–2032

3.2 Introduction by Structure

3.2.1 Membrane-Based Dual-Channel Type

3.2.2 3D Matrix-Embedded Tubular Type

3.2.3 Global Kidney-Organ Chip Sales Value by Structure

3.2.3.1 Global Kidney-Organ Chip Sales Value by Structure (2021 vs 2025 vs 2032)

3.2.3.2 Global Kidney-Organ Chip Sales Value, by Structure (2021–2032)

3.2.3.3 Global Kidney-Organ Chip Sales Value, by Structure (%), 2021–2032

3.3 Introduction by Source

3.3.1 Primary Human Cell-Based Type

3.3.2 Immortalized Cell Line-Based Type

3.3.3 Stem Cell & Organoid-Based Type

3.3.4 Global Kidney-Organ Chip Sales Value by Source

3.3.4.1 Global Kidney-Organ Chip Sales Value by Source (2021 vs 2025 vs 2032)

3.3.4.2 Global Kidney-Organ Chip Sales Value, by Source (2021–2032)

3.3.4.3 Global Kidney-Organ Chip Sales Value, by Source (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Research Institutions

4.1.3 Universities

4.1.4 Others

4.2 Global Kidney-Organ Chip Sales Value by Application

4.2.1 Global Kidney-Organ Chip Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Kidney-Organ Chip Sales Value by Application (2021–2032)

4.2.3 Global Kidney-Organ Chip Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Kidney-Organ Chip Sales Value by Region

5.1.1 Global Kidney-Organ Chip Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Kidney-Organ Chip Sales Value by Region (2021–2026)

5.1.3 Global Kidney-Organ Chip Sales Value by Region (2027–2032)

5.1.4 Global Kidney-Organ Chip Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Kidney-Organ Chip Sales Value, 2021–2032

5.2.2 North America Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Kidney-Organ Chip Sales Value, 2021–2032

5.3.2 Europe Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Kidney-Organ Chip Sales Value, 2021–2032

5.4.2 Asia Pacific Kidney-Organ Chip Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Kidney-Organ Chip Sales Value, 2021–2032

5.5.2 South America Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Kidney-Organ Chip Sales Value, 2021–2032

5.6.2 Middle East & Africa Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Kidney-Organ Chip Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Kidney-Organ Chip Sales Value, 2021–2032

6.3 United States

6.3.1 United States Kidney-Organ Chip Sales Value, 2021–2032

6.3.2 United States Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Kidney-Organ Chip Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Kidney-Organ Chip Sales Value, 2021–2032

6.4.2 Europe Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Kidney-Organ Chip Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Kidney-Organ Chip Sales Value, 2021–2032

6.5.2 China Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

6.5.3 China Kidney-Organ Chip Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Kidney-Organ Chip Sales Value, 2021–2032

6.6.2 Japan Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Kidney-Organ Chip Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Kidney-Organ Chip Sales Value, 2021–2032

6.7.2 South Korea Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Kidney-Organ Chip Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Kidney-Organ Chip Sales Value, 2021–2032

6.8.2 Southeast Asia Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Kidney-Organ Chip Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Kidney-Organ Chip Sales Value, 2021–2032

6.9.2 India Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

6.9.3 India Kidney-Organ Chip Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Emulate

7.1.1 Emulate Profile

7.1.2 Emulate Main Business

7.1.3 Emulate Kidney-Organ Chip Products, Services, and Solutions

7.1.4 Emulate Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.1.5 Emulate Recent Developments

7.2 Mimetas

7.2.1 Mimetas Profile

7.2.2 Mimetas Main Business

7.2.3 Mimetas Kidney-Organ Chip Products, Services, and Solutions

7.2.4 Mimetas Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.2.5 Mimetas Recent Developments

7.3 TissUse

7.3.1 TissUse Profile

7.3.2 TissUse Main Business

7.3.3 TissUse Kidney-Organ Chip Products, Services, and Solutions

7.3.4 TissUse Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.3.5 TissUse Recent Developments

7.4 Valo Health

7.4.1 Valo Health Profile

7.4.2 Valo Health Main Business

7.4.3 Valo Health Kidney-Organ Chip Products, Services, and Solutions

7.4.4 Valo Health Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.4.5 Valo Health Recent Developments

7.5 CN Bio Innovations

7.5.1 CN Bio Innovations Profile

7.5.2 CN Bio Innovations Main Business

7.5.3 CN Bio Innovations Kidney-Organ Chip Products, Services, and Solutions

7.5.4 CN Bio Innovations Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.5.5 CN Bio Innovations Recent Developments

7.6 Draper Laboratory

7.6.1 Draper Laboratory Profile

7.6.2 Draper Laboratory Main Business

7.6.3 Draper Laboratory Kidney-Organ Chip Products, Services, and Solutions

7.6.4 Draper Laboratory Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.6.5 Draper Laboratory Recent Developments

7.7 Nortis

7.7.1 Nortis Profile

7.7.2 Nortis Main Business

7.7.3 Nortis Kidney-Organ Chip Products, Services, and Solutions

7.7.4 Nortis Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.7.5 Nortis Recent Developments

7.8 Xona Microfluidics

7.8.1 Xona Microfluidics Profile

7.8.2 Xona Microfluidics Main Business

7.8.3 Xona Microfluidics Kidney-Organ Chip Products, Services, and Solutions

7.8.4 Xona Microfluidics Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.8.5 Xona Microfluidics Recent Developments

7.9 SynVivo

7.9.1 SynVivo Profile

7.9.2 SynVivo Main Business

7.9.3 SynVivo Kidney-Organ Chip Products, Services, and Solutions

7.9.4 SynVivo Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.9.5 SynVivo Recent Developments

7.10 Beijing Daxiang Biotech

7.10.1 Beijing Daxiang Biotech Profile

7.10.2 Beijing Daxiang Biotech Main Business

7.10.3 Beijing Daxiang Biotech Kidney-Organ Chip Products, Services, and Solutions

7.10.4 Beijing Daxiang Biotech Kidney-Organ Chip Revenue (US$ Million), 2021–2026

7.10.5 Beijing Daxiang Biotech Recent Developments

8 Industry Chain Analysis

8.1 Kidney-Organ Chip Value Chain

8.2 Kidney-Organ Chip Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Kidney-Organ Chip Sales Model

8.5.2 Sales Channels

8.5.3 Kidney-Organ Chip Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Kidney-Organ Chip Market Trends

Table 2. Kidney-Organ Chip Market Drivers & Opportunities

Table 3. Kidney-Organ Chip Market Challenges

Table 4. Kidney-Organ Chip Market Restraints

Table 5. Global Kidney-Organ Chip Revenue by Company (US$ Million), 2021–2026

Table 6. Global Kidney-Organ Chip Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Kidney-Organ Chip Product Type

Table 9. Key Companies General Availability (GA) Timeline for Kidney-Organ Chip

Table 10. Global Kidney-Organ Chip Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Kidney-Organ Chip revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Kidney-Organ Chip Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Kidney-Organ Chip Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Kidney-Organ Chip Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Kidney-Organ Chip Sales Market Share in Value by Type (2021–2026)

Table 17. Global Kidney-Organ Chip Sales Market Share in Value by Type (2027–2032)

Table 18. Global Kidney-Organ Chip Sales Value by Structure: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Kidney-Organ Chip Sales Value by Structure (US$ Million), 2021–2026

Table 20. Global Kidney-Organ Chip Sales Value by Structure (US$ Million), 2027–2032

Table 21. Global Kidney-Organ Chip Sales Market Share in Value by Structure (2021–2026)

Table 22. Global Kidney-Organ Chip Sales Market Share in Value by Structure (2027–2032)

Table 23. Global Kidney-Organ Chip Sales Value by Source: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Kidney-Organ Chip Sales Value by Source (US$ Million), 2021–2026

Table 25. Global Kidney-Organ Chip Sales Value by Source (US$ Million), 2027–2032

Table 26. Global Kidney-Organ Chip Sales Market Share in Value by Source (2021–2026)

Table 27. Global Kidney-Organ Chip Sales Market Share in Value by Source (2027–2032)

Table 28. Global Kidney-Organ Chip Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Kidney-Organ Chip Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Kidney-Organ Chip Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Kidney-Organ Chip Sales Market Share in Value by Application (2021–2026)

Table 32. Global Kidney-Organ Chip Sales Market Share in Value by Application (2027–2032)

Table 33. Global Kidney-Organ Chip Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Kidney-Organ Chip Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Kidney-Organ Chip Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Kidney-Organ Chip Sales Value by Region (%), 2021–2026

Table 37. Global Kidney-Organ Chip Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Kidney-Organ Chip Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Kidney-Organ Chip Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Kidney-Organ Chip Sales Value, (US$ Million), 2027–2032

Table 41. Emulate Basic Information List

Table 42. Emulate Description and Business Overview

Table 43. Emulate Kidney-Organ Chip Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Kidney-Organ Chip Business of Emulate (2021–2026)

Table 45. Emulate Recent Developments

Table 46. Mimetas Basic Information List

Table 47. Mimetas Description and Business Overview

Table 48. Mimetas Kidney-Organ Chip Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Kidney-Organ Chip Business of Mimetas (2021–2026)

Table 50. Mimetas Recent Developments

Table 51. TissUse Basic Information List

Table 52. TissUse Description and Business Overview

Table 53. TissUse Kidney-Organ Chip Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Kidney-Organ Chip Business of TissUse (2021–2026)

Table 55. TissUse Recent Developments

Table 56. Valo Health Basic Information List

Table 57. Valo Health Description and Business Overview

Table 58. Valo Health Kidney-Organ Chip Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Kidney-Organ Chip Business of Valo Health (2021–2026)

Table 60. Valo Health Recent Developments

Table 61. CN Bio Innovations Basic Information List

Table 62. CN Bio Innovations Description and Business Overview

Table 63. CN Bio Innovations Kidney-Organ Chip Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Kidney-Organ Chip Business of CN Bio Innovations (2021–2026)

Table 65. CN Bio Innovations Recent Developments

Table 66. Draper Laboratory Basic Information List

Table 67. Draper Laboratory Description and Business Overview

Table 68. Draper Laboratory Kidney-Organ Chip Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Kidney-Organ Chip Business of Draper Laboratory (2021–2026)

Table 70. Draper Laboratory Recent Developments

Table 71. Nortis Basic Information List

Table 72. Nortis Description and Business Overview

Table 73. Nortis Kidney-Organ Chip Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Kidney-Organ Chip Business of Nortis (2021–2026)

Table 75. Nortis Recent Developments

Table 76. Xona Microfluidics Basic Information List

Table 77. Xona Microfluidics Description and Business Overview

Table 78. Xona Microfluidics Kidney-Organ Chip Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Kidney-Organ Chip Business of Xona Microfluidics (2021–2026)

Table 80. Xona Microfluidics Recent Developments

Table 81. SynVivo Basic Information List

Table 82. SynVivo Description and Business Overview

Table 83. SynVivo Kidney-Organ Chip Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Kidney-Organ Chip Business of SynVivo (2021–2026)

Table 85. SynVivo Recent Developments

Table 86. Beijing Daxiang Biotech Basic Information List

Table 87. Beijing Daxiang Biotech Description and Business Overview

Table 88. Beijing Daxiang Biotech Kidney-Organ Chip Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Kidney-Organ Chip Business of Beijing Daxiang Biotech (2021–2026)

Table 90. Beijing Daxiang Biotech Recent Developments

Table 91. Revenue (US$ Million) in Kidney-Organ Chip Business of Company 40 (2021–2026)

Table 92. Company 40 Recent Developments

Table 93. Key Raw Materials Lists

Table 94. Key Suppliers of Raw Materials Lists

Table 95. Kidney-Organ Chip Downstream Customers

Table 96. Kidney-Organ Chip Distributors List

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Kidney-Organ Chip Product Picture

Figure 2. Global Kidney-Organ Chip Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 4. Kidney-Organ Chip Report Years Considered

Figure 5. Global Kidney-Organ Chip Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Kidney-Organ Chip Revenue in 2025

Figure 7. Kidney-Organ Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Glomerular Chip Picture

Figure 9. Renal Tubule Chip Picture

Figure 10. Colliding Duct Chip Picture

Figure 11. Global Kidney-Organ Chip Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Kidney-Organ Chip Sales Value Market Share by Type, 2025 & 2032

Figure 13. Membrane-Based Dual-Channel Type Picture

Figure 14. 3D Matrix-Embedded Tubular Type Picture

Figure 15. Global Kidney-Organ Chip Sales Value by Structure (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Kidney-Organ Chip Sales Value Market Share by Structure, 2025 & 2032

Figure 17. Primary Human Cell-Based Type Picture

Figure 18. Immortalized Cell Line-Based Type Picture

Figure 19. Stem Cell & Organoid-Based Type Picture

Figure 20. Global Kidney-Organ Chip Sales Value by Source (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Kidney-Organ Chip Sales Value Market Share by Source, 2025 & 2032

Figure 22. Product Picture of Hospitals

Figure 23. Product Picture of Research Institutions

Figure 24. Product Picture of Universities

Figure 25. Product Picture of Others

Figure 26. Global Kidney-Organ Chip Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 27. Global Kidney-Organ Chip Sales Value Market Share by Application, 2025 & 2032

Figure 28. North America Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 29. North America Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

Figure 30. Europe Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 31. Europe Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

Figure 32. Asia Pacific Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 33. Asia Pacific Kidney-Organ Chip Sales Value by Subregion (%), 2025 vs 2032

Figure 34. South America Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 35. South America Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

Figure 36. Middle East & Africa Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 37. Middle East & Africa Kidney-Organ Chip Sales Value by Country (%), 2025 vs 2032

Figure 38. Key Countries/Regions Kidney-Organ Chip Sales Value (%), 2021–2032

Figure 39. United States Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 40. United States Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

Figure 41. United States Kidney-Organ Chip Sales Value by Application (%), 2025 vs 2032

Figure 42. Europe Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 43. Europe Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

Figure 44. Europe Kidney-Organ Chip Sales Value by Application (%), 2025 vs 2032

Figure 45. China Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 46. China Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

Figure 47. China Kidney-Organ Chip Sales Value by Application (%), 2025 vs 2032

Figure 48. Japan Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 49. Japan Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

Figure 50. Japan Kidney-Organ Chip Sales Value by Application (%), 2025 vs 2032

Figure 51. South Korea Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 52. South Korea Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

Figure 53. South Korea Kidney-Organ Chip Sales Value by Application (%), 2025 vs 2032

Figure 54. Southeast Asia Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 55. Southeast Asia Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

Figure 56. Southeast Asia Kidney-Organ Chip Sales Value by Application (%), 2025 vs 2032

Figure 57. India Kidney-Organ Chip Sales Value (US$ Million), 2021–2032

Figure 58. India Kidney-Organ Chip Sales Value by Type (%), 2025 vs 2032

Figure 59. India Kidney-Organ Chip Sales Value by Application (%), 2025 vs 2032

Figure 60. Kidney-Organ Chip Value Chain

Figure 61. Kidney-Organ Chip Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

Related Reports

Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-02-23
Pages: 105
USD 2900.00
(Single User License)
Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-04-26
Pages: 115
USD 4900.00
(Single User License)
Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Kidney-Organ Chip market is projected to grow from US$ 35.29 million in 2025 to US$ 73.18 million by 2032, at a CAGR of 10.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-02
Pages: 124
USD 4900.00
(Single User License)
Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Kidney-Organ Chip market size was US$ 35.29 million in 2025 and is forecast to reach a readjusted size of US$ 73.18 million by 2032 with a CAGR of 10.5% during the forecast period 2026-2032.
Published Date: 2026-08-02
Pages: 108
USD 4250.00
(Single User License)
Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032
The global Kidney-Organ Chip market was valued at US$ 35.29 million in 2025 and is anticipated to reach US$ 73.18 million by 2032, at a CAGR of 10.5% from 2026 to 2032.
Published Date: 2026-08-02
Pages: 104
USD 2900.00
(Single User License)

Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-02-23
Pages: 105
USD 2900.00 (Single User License)
Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-04-26
Pages: 115
USD 4900.00 (Single User License)
Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Kidney-Organ Chip market is projected to grow from US$ 35.29 million in 2025 to US$ 73.18 million by 2032, at a CAGR of 10.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-02
Pages: 124
USD 4900.00 (Single User License)
Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Kidney-Organ Chip market size was US$ 35.29 million in 2025 and is forecast to reach a readjusted size of US$ 73.18 million by 2032 with a CAGR of 10.5% during the forecast period 2026-2032.
Published: 2026-08-02
Pages: 108
USD 4250.00 (Single User License)
Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032
The global Kidney-Organ Chip market was valued at US$ 35.29 million in 2025 and is anticipated to reach US$ 73.18 million by 2032, at a CAGR of 10.5% from 2026 to 2032.
Published: 2026-08-02
Pages: 104
USD 2900.00 (Single User License)